Skip 
Navigation Link

1215 South Walnut Ave.
Demopolis, AL 36732 map map 

Access to Care: 1-800-239-2901

Medical Disorders
Resources
Basic InformationLookupsLatest News
COVID-19 Causing More Stress in America Than Other Nations: SurveyPandemic Could Complicate Hurricane Season11 States Could Face ICU Doc Shortages as Coronavirus Cases SurgeYet Another Study Finds Vaccines Are SafeIn Rush to Publish, Most COVID-19 Research Isn't Reliable, Experts SayMany U.S. Homes Too Cramped to Stop COVID-19's SpreadWith Safety Steps, Moms Unlikely to Pass COVID-19 to Newborns: StudyFace Masks Making Things Tough for the DeafU.S. Air Quality Got Better During Pandemic: StudyWill CPR Save Your Life? Study Offers a Surprising AnswerLupus Drug Prevents Low Heartbeat in High-Risk Newborns: StudyMasks, Video Calls: Pandemic Is Hampering Communication for Those With Hearing ProblemsCOVID-19 Deaths Have Already Left 1.2 Million Americans GrievingWill COVID Pandemic's Environmental Benefit Last?Exposure to Iodine in the NICU May Affect Infant Thyroid FunctionZika May Have Damaged More Infants' Brains Than ExpectedCoronavirus Ups Anxiety, Depression in the LGBTQ CommunityWill the COVID-19 Pandemic Leave a Mental Health Crisis in Its Wake?AHA News: Sadness and Isolation of Pandemic Can Make Coping With Grief HarderWildfire Smoke Causes Rapid Damage to Your Health: StudyCOVID-19 Typically Mild for Babies: StudyOne-Time Treatment Eases Parkinson's -- in MiceDrug Might Relieve Low Back Pain in Whole New WayBlood Donors Will Get Results of Coronavirus Antibody Test, Red Cross SaysAre Hardened Arteries a Risk Factor for Poor Slumber?Can Talk Therapy Heal the Body, Too?COVID Got You Scared of Performing CPR? Study Finds Infection Risk Is LowHealthDay In-Depth
The AI Revolution: Robots Already Helping Humans Deliver Better Care">HealthDay In-Depth
The AI Revolution: Robots Already Helping Humans Deliver Better Care
People With Intellectual Disabilities Are Being Hit Hard by COVID-19Fewer Suicide-Related ER Visits in COVID Era, and That Has Experts Worried'Psychological Distress' Has Tripled in U.S. During Pandemic, Survey ShowsPeople Are Avoiding the ER During COVID-19 Crisis at Their Peril: StudyCoronavirus Pandemic Spurring Mental Health Crisis, Especially in the YoungAHA News: Looking for Ways to Protect Against Pandemic PTSDAs Postponed Surgeries Resume, Can U.S. Hospitals Handle the Strain?Most Americans Still More Worried About COVID-19 Spread Than the EconomyBig Need for Blood Donations as Postponed Surgeries ResumeAHA News: How Bacteria in Your Gut Interact With the Mind and BodyMusic Might Help Soothe Ailing HeartsCould an Injected Electrode Control Your Pain Without Drugs?A New Hip or Knee Can Do a Marriage Good, Study FindsOnly Half of Americans Say They'd Get a Coronavirus Vaccine: SurveyLockdown Got You Down? Experts Offer Tips to De-StressPTSD May Plague Nurses, Especially in COVID-19 EraDepression, Anxiety, PTSD May Plague Many COVID-19 SurvivorsAHA News: Caregiving Is Never Easy, and COVID-19 Has Made It HarderLayoffs and Losses: COVID-19 Leaves U.S. Hospitals in Financial CrisisFDA Goes After Unproven COVID-19 Antibody TestsDuring Droughts, Many Poor Americans Will Lack Clean Tap Water: StudyLove in the Time of Coronavirus: Couples Feel the Strain of Lockdown
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Lupus Drug Prevents Low Heartbeat in High-Risk Newborns: Study

HealthDay News
by -- Robert Preidt
Updated: Jul 17th 2020

new article illustration

FRIDAY, July 17, 2020 (HealthDay News) -- A drug used to treat lupus and malaria -- hydroxychloroquine -- reduced by half the risk of a potentially fatal heart condition in newborns who were at high risk for it.

The condition -- known as congenital heart block (CHB) -- results in a dangerously low heart rate.

"Our study shows hydroxychloroquine as the first, safe, and highly effective drug for preventing pregnant women at risk from having another child with congenital heart block," said lead author and rheumatologist Dr. Peter Izmirly, associate professor of medicine at NYU Langone Health in New York City.

Congenital heart block affects as many as 1 in 15,000 live births. About 75% of babies who survive it will require at least one pacemaker during their lifetime, and some may need a heart transplant.

CHB occurs when a pregnant woman's immune system attacks the heart of her fetus. In about half of cases, the mother has an autoimmune condition such as systemic lupus erythematosus or Sjogren's syndrome.

CHB is linked to antibodies in the mother that react with other proteins called SSA/Ro. For mothers with these antibodies, the risk of a baby with heart block is 2%, but it increases ninefold if a previous pregnancy resulted in CHB.

For newborns, a normal resting heart rate is 120 to 160 beats a minute. A heart rate below 50 beats a minute can be fatal.

This study included 54 U.S. women who previously had a newborn affected by CHB. Starting in their first trimester, the women received 400 milligrams of hydroxychloroquine a day.

Overall, 7.9% of newborns born to women taking hydroxychloroquine had CHB, compared to the historical rate of 18%, according to the study published online July 13 in the Journal of the American College of Cardiology.

Senior author Jill Buyon, director of the Division of Rheumatology at NYU Langone, said testing for anti-SSA/Ro antibodies should be considered. It is not part of a woman's normal screening during pregnancy.

"One implication of our findings is that hydroxychloroquine could be effective in preventing CHB in newborns of first-time, pregnant women with anti-SSA/Ro antibodies, which could change the way we evaluate all pregnancies regardless of a mother's health," Buyon said in an NYU news release.

More information

The U.S. National Institutes of Health has more on congenital heart block.